Sanofi bought LTGO
August 10, 2026 · Form 4 insider transaction
Sanofi bought 177,978 shares of LTGO, a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
177,978
Price
N/A
Total value
N/A
InsiderSanofi
Role10% owner
CompanyLTGO
SecurityCommon Stock
Transaction codeC: Conversion of a derivative
Transaction dateAugust 10, 2026
Filing dateAugust 12, 2026
Shares owned after672,788
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The principal amount of the convertible promissory note (the "Note"), together with any accrued but unpaid interest, automatically converted into shares of common stock upon the closing of the IPO at a conversion price equal to the IPO price of the common stock.; Sanofi beneficially owns the securities reported herein through various wholly-owned subsidiaries.